121 related articles for article (PubMed ID: 11134753)
1. Hepatitis C virus infection and liver transplantation.
Macedo G; Costa Maia J; Gomes A; Ribeiro LM; Carneiro F; Teixeira A; Tomé Ribeiro A
Transplant Proc; 2000 Dec; 32(8):2667. PubMed ID: 11134753
[No Abstract] [Full Text] [Related]
2. Liver transplantation in Chinese patients with chronic hepatitis B.
Jeng LB; Lee WC; Hung CM; Lin DY; Liaw YF; Tan PP; Chen MF
Transplant Proc; 2000 Nov; 32(7):2162-3. PubMed ID: 11120114
[No Abstract] [Full Text] [Related]
3. Clinical outcomes of chronic hepatitis C patients related to baseline liver fibrosis stage: a hospital-based linkage study.
Huang Y; de Boer WB; Adams LA; MacQuillan G; Bulsara MK; Jeffrey GP
Intern Med J; 2015 Jan; 45(1):48-54. PubMed ID: 25371273
[TBL] [Abstract][Full Text] [Related]
4. Orthotopic liver transplantation for liver cirrhosis due to hepatitis C virus in patients with hemophilia A: two benefits of one procedure.
Wawrzynowicz-Syczewska M; Czupryńska M; Bander D; Cyprys S; Post M; Zeair S
Pol Arch Med Wewn; 2014; 124(6):338-9. PubMed ID: 24781929
[No Abstract] [Full Text] [Related]
5. Hepatitis C virus recurrence after liver transplantation: biomarkers of disease and fibrosis progression.
Maluf DG; Archer KJ; Villamil F; Stravitz RT; Mas V
Expert Rev Gastroenterol Hepatol; 2010 Aug; 4(4):445-58. PubMed ID: 20678018
[TBL] [Abstract][Full Text] [Related]
6. Influence of antiviral therapy on the natural history of hepatitis B virus recurrence after liver transplantation: retrospective study of 14 cases.
Vizuete SG; Encinas JL; Prados E; Haro J; Cuervas-Mons V
Transplant Proc; 1999 Sep; 31(6):2461-3. PubMed ID: 10500671
[No Abstract] [Full Text] [Related]
7. Sex difference in liver-related mortality and transplantation associated with dietary cholesterol in chronic hepatitis C virus infection.
Yu L; Morishima C; Ioannou GN
Br J Nutr; 2016 Jan; 115(2):193-201. PubMed ID: 26541123
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of pretransplant and posttransplant viral cirrhosis].
Suárez FJ; Otero A; Gómez M; Souto J; Vázquez-Iglesias JL
Gastroenterol Hepatol; 2001 Feb; 24 Suppl 1():58-63. PubMed ID: 11279895
[No Abstract] [Full Text] [Related]
9. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
de Arias AE; Haworth SE; Belli LS; Burra P; Pinzello G; Vangeli M; Minola E; Guido M; Boccagni P; De Feo TM; Torelli R; Cardillo M; Scalamogna M; Poli F
Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
[TBL] [Abstract][Full Text] [Related]
10. Ten years of experience of liver transplantation in Singapore.
Wai CT; Lo SK; Lee KH; Tan CK; Aw MM; Quak SH; Isacc J; Prabhakaran K; Lim SG; Tan KC
Transplant Proc; 2000 Nov; 32(7):2139. PubMed ID: 11120104
[No Abstract] [Full Text] [Related]
11. Recurrence of hepatitis C after liver transplantation: follow-up and treatment.
Dumortier J; Scoazec JY; Berger F; Boillot O
Transplant Proc; 2002 May; 34(3):779-81. PubMed ID: 12034181
[No Abstract] [Full Text] [Related]
12. Angiotensin II antagonists in patients with recurrent hepatitis C virus infection after liver transplantation.
Cholongitas E; Vibhakorn S; Lodato F; Burroughs AK
Liver Int; 2010 Feb; 30(2):334-5. PubMed ID: 19515217
[No Abstract] [Full Text] [Related]
13. Management of liver transplantation waiting list for decompensated cirrhosis in a Spanish tertiary hospital: differences between hepatitis C virus recipients and other etiologies.
Ibáñez Samaniego L; Pérez Valderas M; Fernández Yunquera A; Rincón Rodríguez D; López Baena JA; Matilla Peña A; Catalina Rodríguez MV; Clemente Ricote G; Bañares Cañizares R; Salcedo Plaza M
Transplant Proc; 2014 Nov; 46(9):3084-6. PubMed ID: 25420829
[TBL] [Abstract][Full Text] [Related]
14. Living donor liver transplantation for hepatitis C virus cirrhosis with a huge portal vein aneurysm.
Miyazaki K; Takatsuki M; Eguchi S; Hidaka M; Tokai H; Hamasaki K; Tajima Y; Kanematsu T
Liver Transpl; 2008 Aug; 14(8):1221-2. PubMed ID: 18668657
[No Abstract] [Full Text] [Related]
15. [Hepatitis C and liver transplantation].
Durand F
Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B82-90. PubMed ID: 12180312
[No Abstract] [Full Text] [Related]
16. The Tor Vergata weaning of immunosuppression protocols in stable hepatitis C virus liver transplant patients: the 10-year follow-up.
Manzia TM; Angelico R; Baiocchi L; Toti L; Ciano P; Palmieri G; Angelico M; Orlando G; Tisone G
Transpl Int; 2013 Mar; 26(3):259-66. PubMed ID: 23278973
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous splenectomy during liver transplantation augments anti-viral therapy in patients infected with hepatitis C virus.
Chu HC; Hsieh CB; Hsu KF; Fan HL; Hsieh TY; Chen TW
Am J Surg; 2015 Jan; 209(1):180-6. PubMed ID: 24928331
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcome of hepatitis C infection after liver transplantation.
Gane EJ; Portmann BC; Naoumov NV; Smith HM; Underhill JA; Donaldson PT; Maertens G; Williams R
N Engl J Med; 1996 Mar; 334(13):815-20. PubMed ID: 8596547
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcome after liver transplantation in Egyptians transplanted for hepatitis C virus cirrhosis.
Khalaf H
Transplant Proc; 2003 Nov; 35(7):2777-8. PubMed ID: 14612116
[No Abstract] [Full Text] [Related]
20. Reply: Prospective validation of a noninvasive index for predicting liver fibrosis in hepatitis C virus-infected liver transplant recipients.
Cross TJ; Burroughs AK; Harrison PM
Liver Transpl; 2010 Jun; 16(6):789-90; author reply 791-2. PubMed ID: 20517916
[No Abstract] [Full Text] [Related]
[Next] [New Search]
